3.43
+0.34(+11.00%)
Currency In USD
| Previous Close | 3.09 |
| Open | 3.1 |
| Day High | 3.46 |
| Day Low | 3.08 |
| 52-Week High | 3.47 |
| 52-Week Low | 1.34 |
| Volume | 929,346 |
| Average Volume | 341,709 |
| Market Cap | 98.81M |
| PE | -4.45 |
| EPS | -0.77 |
| Moving Average 50 Days | 2.31 |
| Moving Average 200 Days | 2.15 |
| Change | 0.34 |
If you invested $1000 in Immix Biopharma, Inc. (IMMX) since IPO date, it would be worth $934.6 as of October 24, 2025 at a share price of $3.43. Whereas If you bought $1000 worth of Immix Biopharma, Inc. (IMMX) shares 3 years ago, it would be worth $3,090.09 as of October 24, 2025 at a share price of $3.43.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Immix Biopharma to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference
GlobeNewswire Inc.
Oct 14, 2025 12:45 PM GMT
LOS ANGELES, CA, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), the global leader in relapsed/refractory AL Amyloidosis, today announced that it will present and host institutional investor
Immix Biopharma to Present Abstract at the upcoming ASH 2025 Annual Meeting
GlobeNewswire Inc.
Oct 06, 2025 8:05 PM GMT
Los Angeles, CA, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), the global leader in relapsed/refractory AL Amyloidosis, today announced that it will present a NXC-201 abstract at the upcomi
Immix Biopharma to Present at the 37th Annual Piper Sandler Healthcare Conference
GlobeNewswire Inc.
Oct 01, 2025 12:45 PM GMT
Los Angeles, CA, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and other serious diseases, today anno